Other
Journal
About P&T Journal
Contacts:Editor:
ssherritze@medimedia.com
Advertising:
mliberti@medimedia.com
Circulation:
lgardineer@medimedia.com
Production:
wpeart@medimedia.com
Rate Card
Production Specifications
Statement of Purpose
Guidelines for Authors
Masthead
Editorial Board
Reprints
Recent Issues
September 2011
Features
Q&A
A Conversation With Ruth M. Parker, MD
Are We Finally Getting Somewhere With Health Literacy in the U.S.?
One-third of patients cannot read or understand their prescription labels and
related medication materials. Dr. Parker, a clinician educator, discusses her
collaborations with other professionals in the effort to tackle the widespread
problem of limited health literacy.
Sonja Sherritze, Editor, P&T
Health Literacy in the Pharmacy
Practical Strategies to Improve Communication With Patients
Poor health literacy is a major cause of the inability of patients to take their
medications properly. This article discusses strategies that can be implemented at both the individual and the system levels.
Adam Carlisle, MD; Kara L. Jacobson, MPH; Lorenzo Di Francesco, MD; and Ruth M. Parker, MD
Role of Maintenance Rituximab (Rituxan) Therapy in the Treatment of Follicular Lymphoma
Maintenance treatment with rituximab has been found to improve outcomes in
patients with both untreated and relapsed follicular lymphoma. However, more
studies are needed to determine the optimal timing, schedule, and duration of
therapy.
Nathan H. Fowler, MD
Meeting Highlights
15th International Congress of Parkinson’s Disease and Movement Disorders and Inaugural Melanoma and Cutaneous Malignancy Meeting
At the movement disorders meeting, therapies included incobotulinumtoxinA
(Xeomin) for blepharospasm and cervical dystonia, a rotigotine patch (Neupro)
for restless legs syndrome, and a carbidopa/levodopa capsule (IPX066) for
Parkinson’s disease. Topics covered at the melanoma meeting included interferon and three novel intralesional therapies (Allovectin, OncoVex, and Rose Bengal).
Departments
Medication Errors
Intimidation by Superiors Affects the Safety of Medical Orders
Staff members often feel too intimidated to question superiors about potential prescribing errors.
Matthew Grissinger, RPh, FASCP
Prescription: Washington
New Proposed HIPAA Disclosures Vex Health Care Players
Who Is Asking for the Information Anyway?
New HIPAA, HITECH provisions will make things more complicated for pharmacists and their software systems.
Stephen Barlas
Pharmaceutical Approval Update
Brilinta for ACS, Xarelto for DVT, and Arcapta Neohaler for COPD
Marvin M. Goldenberg, PhD, RPh, MS
New Drugs/Drug News/New Medical Devices
FDA approvals, drug indications, and updates
Drug Forecast
Vorapaxar: Targeting a Novel Antiplatelet Pathway
Vorapaxar, an investigational antiplatelet agent
Younos Abdulsattar, PharmD, BCPS; Theologia Ternas, PharmD; and Danielle Garcia, PharmD
